Cargando…
CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switches
BACKGROUND: CD40 is a 48 kDa type I transmembrane protein that is constitutively expressed on hematopoietic cells such as dendritic cells, macrophages, and B cells. Engagement of CD40 by CD40L expressed on T cells results in the production of proinflammatory cytokines, induces T helper cell function...
Autores principales: | Argiriadi, Maria A., Benatuil, Lorenzo, Dubrovska, Ievgeniia, Egan, David A., Gao, Lei, Greischar, Amy, Hardman, Jennifer, Harlan, John, Iyer, Ramesh B., Judge, Russell A., Lake, Marc, Perron, Denise C., Sadhukhan, Ramkrishna, Sielaff, Bernhard, Sousa, Silvino, Wang, Rui, McRae, Bradford L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683420/ https://www.ncbi.nlm.nih.gov/pubmed/31382872 http://dx.doi.org/10.1186/s12860-019-0213-4 |
Ejemplares similares
-
CD40–CD40L in Neurological Disease
por: Ots, Heather D., et al.
Publicado: (2022) -
The Role of CD40/CD40 Ligand Interactions in Bone Marrow Granulopoiesis
por: Mavroudi, Irene, et al.
Publicado: (2011) -
The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
por: Bosmans, Laura A., et al.
Publicado: (2020) -
CD40/CD40L expression and its prognostic value in cervical cancer
por: Grazia, G.A., et al.
Publicado: (2023) -
CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation
por: Elmetwali, Taha, et al.
Publicado: (2020)